6.00
Galectin Therapeutics Inc stock is traded at $6.00, with a volume of 582.73K.
It is up +3.27% in the last 24 hours and up +38.57% over the past month.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
See More
Previous Close:
$5.81
Open:
$5.65
24h Volume:
582.73K
Relative Volume:
1.89
Market Cap:
$384.36M
Revenue:
-
Net Income/Loss:
$-45.08M
P/E Ratio:
-8.2192
EPS:
-0.73
Net Cash Flow:
$-33.68M
1W Performance:
+17.65%
1M Performance:
+38.57%
6M Performance:
+331.65%
1Y Performance:
+140.00%
Galectin Therapeutics Inc Stock (GALT) Company Profile
Name
Galectin Therapeutics Inc
Sector
Industry
Phone
678-620-3186
Address
4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA
Compare GALT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
GALT
Galectin Therapeutics Inc
|
6.00 | 374.62M | 0 | -45.08M | -33.68M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-17-25 | Resumed | H.C. Wainwright | Buy |
| Aug-13-20 | Reiterated | H.C. Wainwright | Buy |
| Feb-13-19 | Initiated | B. Riley FBR | Buy |
| Dec-07-17 | Reiterated | H.C. Wainwright | Buy |
| Nov-28-17 | Reiterated | H.C. Wainwright | Buy |
| Oct-19-17 | Initiated | ROTH Capital | Buy |
| Mar-30-17 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Oct-03-16 | Downgrade | FBR & Co. | Outperform → Mkt Perform |
| Sep-29-16 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Sep-28-16 | Downgrade | ROTH Capital | Buy → Sell |
| Mar-28-16 | Resumed | H.C. Wainwright | Buy |
| Sep-21-15 | Initiated | H.C. Wainwright | Buy |
| Aug-01-14 | Downgrade | Aegis Capital | Buy → Hold |
| Jul-30-14 | Reiterated | MLV & Co | Buy |
| Jul-29-14 | Reiterated | MLV & Co | Buy |
| Apr-02-14 | Reiterated | MLV & Co | Buy |
| Feb-10-14 | Reiterated | Aegis Capital | Buy |
| Jan-09-14 | Reiterated | Aegis Capital | Buy |
| Dec-03-13 | Initiated | MLV & Co | Buy |
| Aug-19-13 | Reiterated | Aegis Capital | Buy |
View All
Galectin Therapeutics Inc Stock (GALT) Latest News
What sentiment indicators say about Galectin Therapeutics Inc. stockJuly 2025 Drop Watch & Daily Market Momentum Tracking - newser.com
What is the fair value estimate for Galectin Therapeutics Inc. (PHPN) stock in 2025Day Trade & Community Consensus Trade Alerts - newser.com
Applying Elliott Wave Theory to Galectin Therapeutics Inc.July 2025 Trade Ideas & Daily Chart Pattern Signal Reports - newser.com
What valuation multiples suggest for Galectin Therapeutics Inc. stock2025 Market Overview & Community Consensus Picks - newser.com
Can Galectin Therapeutics Inc. (PHPN) stock sustain margin levelsGDP Growth & Daily Entry Point Trade Alerts - newser.com
Is Galectin Therapeutics Inc. forming a reversal patternRisk Management & Long Hold Capital Preservation Tips - newser.com
Identifying reversal signals in Galectin Therapeutics Inc.Options Play & Free Growth Oriented Trading Recommendations - newser.com
Is Galectin Therapeutics Inc. (PHPN) stock cheap by valuation metrics2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com
Is Galectin Therapeutics Inc. (PHPN) stock among top earnings playsWall Street Watch & Expert Verified Stock Movement Alerts - newser.com
Can you recover from losses in Galectin Therapeutics Inc.2025 Price Momentum & Community Driven Trade Alerts - newser.com
Will Galectin Therapeutics Inc. (PHPN) stock beat growth indexesJuly 2025 Earnings & Weekly Chart Analysis and Guides - newser.com
Will Galectin Therapeutics Inc. stock benefit from green energy trends2025 Fundamental Recap & Long-Term Investment Growth Plans - fcp.pa.gov.br
Why Galectin Therapeutics Inc. (PHPN) stock could rally stronglyJuly 2025 Big Picture & Free Weekly Chart Analysis and Trade Guides - Fundação Cultural do Pará
Galectin Therapeutics Inc. (GALT) Stock forecasts - Yahoo! Finance UK
Will Galectin Therapeutics Inc. stock beat EPS estimatesEarnings Risk Summary & Stepwise Swing Trade Plans - Fundação Cultural do Pará
How risky is Galectin Therapeutics Inc. stock nowTrade Risk Summary & Verified Momentum Watchlists - fcp.pa.gov.br
Galectin Therapeutics Inc Stock (GALT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):